Tablo Sales Boost Outset Bottom Line
Product revenues increased 5.5% and service revenues increased in Q3 of 2022 over 2021. The Tablo is used for acute and home HD, and Outset won a 5-year VA contract for Tablo in hospitals and homes.
Read the full article » | Posted 12-19-2022
Related Articles
- Fresenius Medical Care named Shervin Korangy as CEO Posted 10-22-2026
- Aligning Clinical Excellence with Health System Goals Through PD in Value-Based Models Posted 10-22-2026
- Update on National Institutes of Health websites Posted 10-22-2026
- What to Know About the American Society of Nephrology Kidney Week Posted 10-22-2026

